The landscape of public health in India is marked by a high burden of vector-borne diseases (VBDs), which are a major cause of morbidity and mortality. This article aims to provide a comprehensive review of the prevalence and management of VBDs in India, focusing on diseases such as malaria, dengue, and chikungunya.
India carries a significant burden of VBDs. Malaria, for instance, is endemic in most of the country, with rural and tribal areas being the most affected. Dengue, on the other hand, has emerged as a major public health concern over the last few decades, with urban and semi-urban areas witnessing a surge in cases. Chikungunya, although less prevalent than malaria and dengue, has caused significant outbreaks in several states.
The management of VBDs in India involves a multipronged strategy that includes prevention, early detection, and treatment. Prevention strategies primarily involve vector control measures, such as the use of insecticide-treated nets and indoor residual spraying. Early diagnosis and prompt treatment are crucial for reducing morbidity and preventing complications. The National Vector Borne Disease Control Programme (NVBDCP) plays a pivotal role in the management of VBDs in India, providing guidelines and resources for prevention, diagnosis, and treatment.
The management of VBDs in India faces several challenges, including a lack of awareness, inadequate healthcare infrastructure, and resistance to insecticides. Future efforts should focus on strengthening disease surveillance, improving diagnostic facilities, and enhancing community participation in vector control activities. Research into new vector control methods and treatments is also crucial.
Understanding the prevalence and management of VBDs is critical for healthcare professionals in India. Despite the challenges, significant progress has been made in controlling these diseases. However, sustained efforts are required to further reduce the burden of VBDs and improve public health in India.
1.
A Lot Can Be Said About You by Including Yourself in Photos.
2.
A new blood test greatly increases the ability to detect cancer.
3.
Novel biomarker has potential for predicting and treating skin cancer metastasis
4.
Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC
5.
No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer
1.
Preventing Heparin Induced Thrombocytopenia: Tips for Successful Anticoagulation Therapy
2.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
3.
Contemporary Frameworks in Oncology Across Clinical Settings
4.
What is Mullerian and How Does it Affect Your Health
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding Common Causes of Abnormal Blood Counts
2.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Understanding Cancer: Early Detection and Treatment
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation